Sign In

Andrea Smiley

President and CEO at VMS BioMarketing

Professional Background

Andrea Heslin Smiley is a dynamic leader in the healthcare and biotechnology sectors, currently serving as the President and CEO of VMS BioMarketing. With extensive experience in business development and marketing strategies, Andrea has made significant contributions to various organizations throughout her career.

Before assuming her current role, Andrea held several influential positions that showcase her expertise and leadership abilities. She was a vital member of the Board of Directors at atai Life Sciences, where she contributed to the strategic direction of the company, focused on enabling transformative therapies in neuroscience. Additionally, she served on the Board of Directors of Rockwell Medical, Inc., a biotech company dedicated to providing innovative solutions for patients undergoing dialysis, and at Assertio Corporation, where she helped shape the pharmaceutical pathway to optimize patient outcomes.

Her journey in the healthcare space began at Eli Lilly and Company, where she held various roles, including the Vice President of the Osteoporosis Business Unit and Senior Vice President of Business Development. Her progressive career at Eli Lilly is marked by her leadership over the Diabetes Business Unit and her work in corporate strategy and business development. Andrea's strategic thinking and ability to navigate complex healthcare challenges have made her a sought-after expert in biopharma management.

In addition to her corporate roles, Andrea has also played a significant role in the advisory capacity. She has provided valuable insights as an Advisor at Agent Capital, a firm specializing in innovative healthcare investments, which demonstrates her capability in identifying growth opportunities within the biopharma industry.

Education and Achievements

Andrea holds a Bachelor of Arts in Economics from DePauw University, which has equipped her with a foundational understanding of market dynamics and economic principles that she has successfully applied throughout her career. Her academic background has been pivotal in shaping her analytical approach to business development and investment opportunities in the healthcare sector.

Throughout her professional journey, Andrea has been recognized for her commitment to excellence and her ability to lead teams to success. Her contributions have not only positively impacted the organizations she has been part of but have also set benchmarks for industry best practices.

Achievements

  1. Leadership at VMS BioMarketing: As President and CEO, Andrea has spearheaded initiatives that have propelled VMS BioMarketing into a leading position within the market, establishing strategic partnerships and driving innovative marketing strategies tailored to enhance patient experiences.
  2. Board Governance: Andrea's experience on various boards, including atai Life Sciences, Rockwell Medical, and Assertio Corporation, showcases her breadth of knowledge in guiding organizations to achieve their goals while ensuring sound governance practices.
  3. Transformative Strategies at Eli Lilly: During her tenure at Eli Lilly, Andrea developed and implemented strategies that significantly advanced patient care within the diabetes and osteoporosis markets, demonstrating her ability to align business objectives with patient needs effectively.
  4. Consultative Expertise: As a consultant at Putnam Associates, she supported major pharmaceutical and biotech companies in developing robust market-entry strategies, demonstrating her ability to leverage analytical skills in aiding firms to make informed business decisions.
  5. Early Career Acumen: Her foundational experiences, including her role as a Business Development Analyst at Harvard University, laid the groundwork for her strong analytical skills and understanding of market dynamics in healthcare.

With a remarkable educational background and extensive work experience spanning various critical roles in the healthcare industry, Andrea Heslin Smiley is a proven leader and innovator. Her professional trajectory reflects a commitment to improving healthcare outcomes and a passion for fostering growth in the biopharmaceutical sector.

Related Questions

How has Andrea Heslin Smiley influenced the trajectory of VMS BioMarketing under her leadership?
What key strategies did Andrea Heslin Smiley implement while serving as Vice President at Eli Lilly and Company?
How did Andrea Heslin Smiley’s background in economics contribute to her success in the healthcare industry?
In what ways has Andrea Heslin Smiley impacted the companies she has served on the board of directors?
What innovations in the biopharma space has Andrea Heslin Smiley championed during her career?
A
Add to my network

Location

Indianapolis, Indiana, United States